Home/ Stocks/ RXRX

Recursion Pharmaceuticals, Inc. Class A Common Stock

RXRX XNAS

$3.24 +0.02 (+0.62%) ▲ 15-min delayed

Open

N/A

High

N/A

Low

N/A

Volume

N/A

Market Cap

$1.74B

About Recursion Pharmaceuticals, Inc. Class A Common Stock

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 600 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$7.67M	$-131,005,000	$-0.25
Q1 2026	$6.47M	$-117,504,000	$-0.22
FY 2025	$74.68M	$-644,759,000	$-1.44
Q3 2025	$5.17M	$-162,253,000	$-0.36

Related Market News

No specific coverage for RXRX yet. Check out our latest market news or earnings calendar.

Get RXRX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Recursion Pharmaceuticals, Inc. Class A Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.